LEAPMOTOR (09863) chairman Zhu Jiangming and company shareholder Fu Liquan collectively increased their holding of 4.8142 million shares of company H shares.
Zero Run Automotive (09863) announced that, based on strong confidence in the future development of the company, to promote the company's continuous, stable, and healthy development and protect the interests of the general public investors, the company's shareholder, Chairman and CEO Zhu Jiangming, and shareholder Fu Liqian jointly purchased a total of 4.8142 million H shares of the company in the market recently (this round of increases). The average price is approximately HK$35.86 per share.
LEAPMOTOR (09863) announced that, based on strong confidence in the future development of the company and to promote the continuous, stable, and healthy development of the company, as well as to safeguard the interests of the general public investors, the company's shareholders, Chairman and CEO Mr. Zhu Jiangming, and shareholder Mr. Fu Liquan recently jointly purchased a total of 4.8142 million H-shares of the company in the market (this recent increase in holdings), at an average price of approximately HK$35.86 per share.
Following this recent increase in holdings, as of the date of this announcement, Mr. Zhu Jiangming, Mr. Fu Liquan, and their affiliated single largest shareholder group collectively hold 228 million H-shares and 129 million domestic shares of the company, accounting for 25.05% of the total issued shares of the company. Mr. Zhu Jiangming and Mr. Fu Liquan confirm that this recent increase in holdings complies with relevant laws and regulations as well as the listing rules of The Stock Exchange of Hong Kong Limited. Over the past six months, the company's shareholders, Chairman and CEO Mr. Zhu Jiangming, and shareholder Mr. Fu Liquan have collectively increased their holdings by approximately HK$900 million.
Related Articles

HK Stock Market Move | IMAGI INT'L (00585) rose 24% today. Since the beginning of April, the stock price has risen more than 7.6 times. The long-term investment value of the company is being revalued by the market at an accelerating pace.

Relying on the efficient platform technology, IMMUNEONCO-B (01541) is promoting the upgrade of the IMM2510 formulation, improving the convenience and compliance of cancer patient treatment.

PASHUN INT'L (00574) will be suspended in the afternoon of July 2nd awaiting the publication of insider information.
HK Stock Market Move | IMAGI INT'L (00585) rose 24% today. Since the beginning of April, the stock price has risen more than 7.6 times. The long-term investment value of the company is being revalued by the market at an accelerating pace.

Relying on the efficient platform technology, IMMUNEONCO-B (01541) is promoting the upgrade of the IMM2510 formulation, improving the convenience and compliance of cancer patient treatment.

PASHUN INT'L (00574) will be suspended in the afternoon of July 2nd awaiting the publication of insider information.

RECOMMEND





